Rachael R. Schulte, MD, MS - Pediatric Hematology - Oncology

Rachael R. Schulte, MD, MS

Pediatric Hematology - Oncology

Employed Provider

Accepting Pediatric Patients

317.944.2143 Refer a Patient

Dr. Rachael R. Schulte specializes in Pediatric Hematology-Oncology for Riley Pediatric Cancer & Blood Disorders. Dr. Schulte earned her undergraduate degree right here in Indiana at Indiana State University. She then earned her medical degree, residency, and fellowship from Vanderbilt University School of Medicine, Nashville TN.

Dr. Schulte's primary location is Riley Pediatric Cancer & Blood Disorders, 575 Riley Hospital Dr., Indianapolis, IN 46202. She also sees patients at an office in Carmel.

Riley Pediatric Cancer & Blood Disorders photo Riley Pediatric Cancer & Blood Disorders

575 Riley Hospital Dr.

Hematology/Oncology MSA

Indianapolis, IN, 46202

Get Directions 317.944.2143
Specialties
  • Pediatric Hematology - Oncology
Education
  • Undergraduate: Indiana State University, Terre Haute, IN
  • Masters degree: Vanderbilt University School of Medicine, Nashville, TN
  • School of Medicine: Vanderbilt University School of Medicine, Nashville TN
  • Residency: Vanderbilt University School of Medicine, Nashville TN
  • Fellowship: Vanderbilt University School of Medicine, Nashville TN
Hospitals & Affiliations
  • IU Health North Hospital
  • Riley Physicians
  • IU Health Medical Group
  • Aetna Medicare Advantage
  • Anthem Blue Cross Blue Shield
  • Anthem Healthy Indiana Plan
  • Anthem Hoosier Care Connect
  • Anthem Hoosier Healthwise
  • Anthem Indiana PathWays for Aging
  • Anthem Medicare Advantage HMO
  • Anthem Medicare Advantage PPO
  • Anthem Pathway Essentials Network
  • CareSource Healthy Indiana Plan
  • CareSource Hoosier Healthwise
  • CareSource Marketplace
  • Cigna HealthCare HMO
  • Cigna HealthCare PPO
  • Cigna Marketplace
  • Community Health Network Employee Plan
  • Encore Combined
  • Encore Elite
  • Encore Workers Compensation
  • Health Alliance Medicare Advantage
  • Humana Healthy Horizons Indiana PathWays for Aging
  • Humana Medicare Advantage HMO
  • Humana Medicare Advantage PFFS
  • Humana Medicare Advantage PPO
  • Indiana University Workers Compensation
  • Indiana University Health Workers Compensation
  • Managed Health Services Healthy Indiana Plan
  • Managed Health Services Hoosier Care Connect
  • Managed Health Services Hoosier Healthwise
  • Managed Health Services Marketplace
  • Managed Health Services Medicare Advantage (Allwell)
  • Point Comfort Unaccompanied Children Program
  • United HealthCare Community Plan Indiana PathWays for Aging
  • United HealthCare Hoosier Care Connect
  • United HealthCare Marketplace
  • United HealthCare Medicare Advantage D-SNP
  • United HealthCare Medicare Advantage HMO
  • United HealthCare Medicare Advantage POS
  • United HealthCare Medicare Advantage PPO
  • Zing Health Medicare Advantage C-SNP
  • Zing Health Medicare Advantage D-SNP
  • Zing Health Medicare Advantage HMO
  • Zing Health Medicare Advantage POS
  • Zing Health Medicare Advantage PPO

Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.

Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.

A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy

View Details

A multi-center, open-label study to determine the dose and safety of oral asciminib in pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP), previously treated with one or more tyrosine kinase inhibitors

View Details

A Phase 2 Study of Mutant-Selective Pi3Kα Inhibitor, Rly-2608, in Adults and Children with Pik3Ca Related Overgrowth Spectrum and Malformations Driven by Pik3Ca Mutation

View Details
Search All Clinical Trials
View more about Riley mom: “I never thought this day would come”
Riley mom: “I never thought this day would come”

A Kokomo kindergartner rings the bell surrounded by family as she completes her treatment for leukemia.

Read the Story